Stocks in the Drug Manufacturers - Major Industry

Sector: Healthcare

Drug Manufacturers - Major is an industry that produces pharmaceuticals, biologics, and medical devices. This industry is responsible for the research, development, and production of drugs and medical devices that are used to treat and prevent diseases. The industry is highly regulated and requires companies to adhere to strict safety and quality standards. Companies in this industry are typically large, multinational corporations that have the resources to invest in research and development.


Recent Signals

Date Stock Signal Type
2024-11-01 ABBV Stochastic Reached Overbought Strength
2024-11-01 ABBV Calm After Storm Range Contraction
2024-11-01 ABBV Upper Bollinger Band Walk Strength
2024-11-01 AMGN Bollinger Band Squeeze Range Contraction
2024-11-01 AMGN Cup with Handle Other
2024-11-01 AMGN Fell Below 20 DMA Bearish
2024-11-01 AZN Narrow Range Bar Range Contraction
2024-11-01 AZN NR7 Range Contraction
2024-11-01 AZN Lower Bollinger Band Walk Weakness
2024-11-01 AZN Calm After Storm Range Contraction
2024-11-01 BIIB New 52 Week Closing Low Bearish
2024-11-01 BIIB Doji - Bullish? Reversal
2024-11-01 BIIB New 52 Week Low Weakness
2024-11-01 BIIB Lower Bollinger Band Walk Weakness
2024-11-01 BMY Jack-in-the-Box Bullish Bullish Swing Setup
2024-11-01 BMY New Uptrend Bullish
2024-11-01 GILD Stochastic Reached Overbought Strength
2024-11-01 GILD New 52 Week Closing High Bullish
2024-11-01 GRFS NR7 Range Contraction
2024-11-01 GRFS Narrow Range Bar Range Contraction
2024-11-01 GRFS Stochastic Reached Overbought Strength
2024-11-01 GRFS MACD Bullish Signal Line Cross Bullish
2024-11-01 GRFS Crossed Above 50 DMA Bullish
2024-11-01 GSK Death Cross Bearish
2024-11-01 GSK Slingshot Bearish Bearish Swing Setup
2024-11-01 HCM 50 DMA Resistance Bearish
2024-11-01 LLY Lower Bollinger Band Walk Weakness
2024-11-01 LLY Calm After Storm Range Contraction
2024-11-01 LLY Fell Below 200 DMA Bearish
2024-11-01 MRK Lower Bollinger Band Walk Weakness
2024-11-01 MRK Jack-in-the-Box Bearish Bearish Swing Setup
2024-11-01 NNVC Bollinger Band Squeeze Range Contraction
2024-11-01 NVS Narrow Range Bar Range Contraction
2024-11-01 NVS Lower Bollinger Band Walk Weakness
2024-11-01 NVS Slingshot Bearish Bearish Swing Setup
2024-11-01 NVS Calm After Storm Range Contraction
2024-11-01 PFE Stochastic Reached Oversold Weakness
2024-11-01 PRPH New 52 Week Closing Low Bearish
2024-11-01 TVTX 20 DMA Support Bullish

Recent News for Drug Manufacturers - Major Stocks

Date Stock Title
Nov 1 LLY Lilly to Present Results from Phase 3 EMBER-3 Study of Imlunestrant, an Oral SERD, and Additional Results from Its Breast Cancer Portfolio at the San Antonio Breast Cancer Symposium
Nov 1 SNY Vir Biotechnology Inc (VIR) Q3 2024 Earnings Call Highlights: Strategic Restructuring and ...
Nov 1 LLY Market Volatility Soars Ahead Of Elections, Tech Earnings Mixed, Strikes And Hurricanes Knock Employment Down: This Week In The Markets
Nov 1 LLY Madrigal Catapults After Novo's Wegovy Proves It's No 'Silver Bullet' In MASH
Nov 1 JNJ Stocks that hedge funds moved from long to short in August - Jefferies
Nov 1 BMY Bristol Myers Squibb Stock Gets Relative Strength Rating Upgrade
Nov 1 ABBV Bristol Myers Squibb Stock Gets Relative Strength Rating Upgrade
Nov 1 PFE Pharma Stock Roundup: MRK, PFE, ABBV, NVS, LLY's Q3 Earnings in Focus
Nov 1 ABBV Pharma Stock Roundup: MRK, PFE, ABBV, NVS, LLY's Q3 Earnings in Focus
Nov 1 NVS Pharma Stock Roundup: MRK, PFE, ABBV, NVS, LLY's Q3 Earnings in Focus
Nov 1 LLY Pharma Stock Roundup: MRK, PFE, ABBV, NVS, LLY's Q3 Earnings in Focus
Nov 1 MRK Merck's Gardasil Shot Challenges To Continue, Analysts Optimistic For Newly Approved Sotatercept For Rare Lung Disease
Nov 1 LLY Stocks to watch next week: Berkshire Hathaway, Super Micro, Novo Nordisk, Vistry and M&S
Nov 1 GILD Stocks to watch next week: Berkshire Hathaway, Super Micro, Novo Nordisk, Vistry and M&S
Nov 1 LLY Hims & Hers Health Faces Pressure Ahead of Earnings Amid Eli Lilly's GLP-1 News
Nov 1 BMY Bristol Myers posts long-term Phase 3 data for schizophrenia drug Cobenfy
Nov 1 SNY Kymera Q3 Loss Narrower Than Expected, Pipeline in Focus
Nov 1 PFE 3 Reasons Relying on Social Security Alone Could be a Risk. And 3 Stocks to Invest in Today.
Nov 1 NVS Madrigal Q3 Earnings Beat, NASH Drug Sales Drive Top Line, Stock Up
Nov 1 NVS Alnylam Q3 Loss In Line With Estimates, Revenues Miss, Stock Down